Results 111 to 120 of about 2,785 (177)

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial. [PDF]

Obstet Gynecol, 2019
Lukes AS, Soper D, Harrington A, Sniukiene V, Mo Y, Gillard P, Shulman L.   +6 more
europepmc   +1 more source

Ulipristal acetate as a treatment option for uterine fibroids. [PDF]

Prz Menopauzalny, 2017
Piecak K, Milart P, Woźniakowska E, Paszkowski T.   +3 more
europepmc   +1 more source

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports. [PDF]

Medicine (Baltimore), 2018
Santoro A, Angelico G, Arciuolo D, Inzani F, Fanfani F, Romualdi D, Scambia G, Zannoni GF.   +7 more
europepmc   +1 more source

Corrigendum to "Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate". [PDF]

Biomed Res Int, 2018
Rabe T, Saenger N, Ebert AD, Roemer T, Tinneberg HR, De Wilde RL, Wallwiener M.   +6 more
europepmc   +1 more source

Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial. [PDF]

Obstet Gynecol, 2018
Zigler RE, Madden T, Ashby C, Wan L, McNicholas C.   +4 more
europepmc   +1 more source

Pharmacy access to Ulipristal acetate in major cities throughout the United States. [PDF]

Contraception, 2018
Shigesato M, Elia J, Tschann M, Bullock H, Hurwitz E, Wu YY, Salcedo J.   +6 more
europepmc   +1 more source

1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids. [PDF]

Reprod Sci, 2019
Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q.   +4 more
europepmc   +1 more source

Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix. [PDF]

Int J Mol Med, 2018
Shin SJ, Kim J, Lee S, Baek J, Lee JE, Cho C, Ha E.   +6 more
europepmc   +1 more source

Ulipristal acetate for fibroids. [PDF]

Aust Prescr, 2016
europepmc   +1 more source